Trial Profile
Influence of CD4+ T-cell response to telbivudine on the prevention of hepatitis B-related liver fibrosis progression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 25 Nov 2015 New trial record